The safety of proton pump inhibitors (PPIs) in pregnancy: A meta-analysis

American Journal of Gastroenterology

Volumn 104, Issue 6, 2009, Pages 1541-1545

  Gill, Simerpal K ^a,b   O'Brien, Lisa ^a,c   Einarson, Thomas R ^b   Koren, Gideon ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DRUG SAFETY; HUMAN; META ANALYSIS; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW;

FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 66949155715     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.122     Document Type: Article

References (25)

1. Baron T, Ramirez B, Richter J. Gastrointestinal motility disorders in pregnancy. Ann Intern Med 1993;118:366-75.
2. Ali R, Egan L. Gastroesophageal refux disease in pregnancy. Best Pract Res Clin Gastroenterol 2007;21:793-806.
3. Broussard C, Richter J. Treating gastro-oesophageal reflux during pregnancy and lactation: what are the safest therapy options? Drug Saf 1998;19:325-37.
4. Mahadevan U. Gastrointestinal medications in pregnancy. Best Pract Res Clin Gastroenterol 2007;21:849-77.
5. Richter J. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther 2005;22:749-57.
6. Koch K. Gastrointestinal factors in nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002;186: S198-203.
7. Castro L. Refux esophagitis as the cause of heartburn in pregnancy. Am J Obstet Gynecol 1967;98:1-10.
8. Marrero J, Goggin P, de Caestecker J et al. Determinants of pregnancy heartburn. Br J Obstet Gynaecol 1992;99:731-4.
9. Everson G. Gastrointestinal motility in pregnancy. Gastroenterol Clin North Am 1992;2:751-6.
10. Attard C, Kohli M, Co eman S et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol 2002;186: S220-7.
11. Vanderhof B, Tahboub R. Proton pump inhibitors: an update. Am Fam Physician 2002;66:273-80.
12. Welage L, Berardi R. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J Am Pharm Assoc 2000;40:52-62.
13. Nikfar S, Abdollah M, Moretti M et al. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci 2002;47:1526-9.
14. Downs S, Black N. The feasibility of creating a checklist for the assessment of methodological quality of both randomized and non- randomized studies of health care interventions. J Epidemiol Community Health 1998;52:377-84.
15. Ruigomez A, Rodriguez L, Cattaruzzi C et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999;150:476-81.
16. Nielson G, Sorenson H, Thulstrup A et al. The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther 1999;13:1085-9.
17. Kallen B. Delivery outcome afer the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol 1998;105:877-81.
18. Lalkin A, Loebbstein R, Addis A et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998;179:727-30.
19. Diav-Citran O, Arnon J, Shechtman S et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 2005;21:269-75.
20. Matok I, Gorodischer R Koren G, Levy A. The safety of intrauterine exposure to proton pump inhibitors during the first trimester of pregnancy. The IXth World Conference on Clinical Pharmacology and Therapeutics. Quebec City, Canada, July 2008, Abstract T3T124.
21. Heitland G, Hurlburt KM (eds). REPROTOX database (electronic version). Greenwood Village, CO, USA: Micromedex ® Healthcare Series; Available at: http://www.thomsonhc.com.myaccess.library.utoronto.ca. Accessed 2008 March 26.
22. Källen B. Use of omeprazole during pregnancy - no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol 2001;96:63-8.
23. Richter JE. Gastroesophageal refux disease during pregnancy. Gastroenterol Clin North Am 2003;32:235-61.
24. Moayyedi P, Talley NJ. Gastro-oesophageal refux disease. Lancet 2006;367:2086-100.
25. Richter JE. Gastrooesophageal refux disease. Best Pract Res Clin Gastroenterol 2007;21:609-31.